Skip to main content

Table 4 Shows the mean Quantitative Angiographic Measurement of the included studiesa

From: Comparing the effectiveness and safety between triple antiplatelet therapy and dual antiplatelet therapy in type 2 diabetes mellitus patients after coronary stents implantation: a systematic review and meta-analysis of randomized controlled trials

Variables (mm) TAPT group (n = 377) DAPT group (n = 365)
Reference diameter 2.81 2.79
Lesion length 31.5 31.7
Stented length 37.45 36.05
Minimal lumen diameter in segment before procedure 0.81 0.79
Minimal lumen diameter in segment after procedure 2.25 2.24
Minimal lumen diameter in stent after procedure 2.57 2.58
Stenosis diameter in segment before procedure (%) 70.3 70.4
Stenosis diameter in segment after procedure (%) 17.7 17.2
Stenosis diameter in stent after procedure (%) 8.45 7.57
Acute gain in segment 1.44 1.46
Acute gain in stent 1.76 1.79
  1. aData from trials Lee 2007 [34], Lee 2008 [5] and Lee 2011 [33] have been included in this table. Quantitative Angiographic Measurement data for study Han 2009 [6] was not available and therefore have been omitted